{iframe}http://www.grants.gov/web/grants/view-opportunity.html?oppId=248816{/iframe}
Home » Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D): Towards an Artificial Pancreas (SBIR) (R43/R44) Grant- March 14, 2014
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.
Twitter
Facebook
Linkedin
© 2024 BioHealth Innovation.
You have successfully subscribed to the newsletter
There was an error while trying to send your request. Please try again.